Search

Your search keyword '"Remijn JA"' showing total 20 results

Search Constraints

Start Over You searched for: Author "Remijn JA" Remove constraint Author: "Remijn JA" Search Limiters Full Text Remove constraint Search Limiters: Full Text
20 results on '"Remijn JA"'

Search Results

1. Interference of lupus anticoagulant causing antiprothrombin and anti-beta-2-glycoprotein I antibodies on international normalized ratio measurements: comparative analysis of international normalized ratio methods.

2. Patients With Multiple Myeloma Have a Disbalanced Whole Blood Thrombin Generation Profile.

3. Haemostatic differences between SARS-CoV-2 PCR-positive and negative patients at the time of hospital admission.

4. Association of genetic variations in ACE2, TIRAP and factor X with outcomes in COVID-19.

5. Acute exacerbations of COPD are associated with a prothrombotic state through platelet-monocyte complexes, endothelial activation and increased thrombin generation.

6. Implant stability in patients treated with platelet-rich fibrin and bovine bone substitute for alveolar ridge preservation is associated with peripheral blood cells and coagulation factors.

7. A Hypoxic Environment Attenuates Exercise-Induced Procoagulant Changes Due to Decreased Platelet Activation.

9. Successful soft and hard tissue augmentation with platelet-rich fibrin in combination with bovine bone space maintainer in a delayed implant placement protocol in the esthetic zone: A case report.

10. Analytical characterization and reference interval of an enzyme-linked immunosorbent assay for active von Willebrand factor.

11. Salivary tissue factor induces thrombin generation in a diurnal rhythm.

12. Effects of Plasmin on von Willebrand Factor and Platelets: A Narrative Review.

13. The ethnicity-specific association of biomarkers with the angiographic severity of coronary artery disease.

14. Platelet Activation Test in Unprocessed Blood (Pac-t-UB) to Monitor Platelet Concentrates and Whole Blood of Thrombocytopenic Patients.

15. Citalopram is a more potent platelet function inhibitor than paroxetine in a case-control study.

16. Recombinant thromboplastins vs tissue-extract thromboplastins in patients on unstable oral anticoagulant therapy.

17. Strongly increased international normalized ratio with recombinant Neoplastin R compared with tissue extract Neoplastin Plus in patients initiating oral anticoagulant therapy: implications for anticoagulation dosage.

19. Role of the fibrinogen gamma-chain sequence gamma316-322 in platelet-mediated clot retraction.

20. Role of ADP receptor P2Y(12) in platelet adhesion and thrombus formation in flowing blood.

Catalog

Books, media, physical & digital resources